Similar articles

• The use of immunological markers in IDDM after more than 20 years from ICA description.

  Dotta F, Dionisi S, Farilla L, Di Mario U. Dotta F, et al. Diabetes Metab Rev. 1996 Jul;12(2):121-6. doi: 10.1002/(SICI)1099-0895(199607)12:2<121::AID-DMR160>3.0.CO;2-9. Diabetes Metab Rev. 1996. PMID: 8877281 Review. No abstract available.
• [Contribution of Japanese researchers to the progress of studies in endocrinology and metabolism in the field of internal medicine in the last 100 years: Slowly progressive insulin-dependent diabetes mellitus (SPIDDM)].

  Kobayashi T. Kobayashi T. Nihon Naika Gakkai Zasshi. 2002 Apr 10;91(4):1152-4. Nihon Naika Gakkai Zasshi. 2002. PMID: 12056010 Review. Japanese. No abstract available.
• Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.

  Whittingham S, Byron SL, Tuomilehto J, Zimmet PZ, Myers MA, Vidgren G, Rowley MJ, Feeney SJ, Koskela P, Tuomilehto-Wolf E, Mackay IR. Whittingham S, et al. Diabet Med. 1997 Aug;14(8):678-85. doi: 10.1002/(SICI)1096-9136(199708)14:8<678::AID-DIA451>3.0.CO;2-F. Diabet Med. 1997. PMID: 9272595
• GAD antibodies seldom disappear in slowly progressive IDDM.

  Kobayashi T, Nakanishi K, Okubo M, Murase T, Kosaka K. Kobayashi T, et al. Diabetes Care. 1996 Sep;19(9):1031. doi: 10.2337/diacare.19.9.1031a. Diabetes Care. 1996. PMID: 8875105 No abstract available.
• [Islet cell antibody (ICA)].

  Kobayashi T. Kobayashi T. Nihon Rinsho. 1997 Nov;55 Suppl:328-32. Nihon Rinsho. 1997. PMID: 9434489 Review. Japanese. No abstract available.